Gut Health
What Is the Connection Between Eczema and Gut Health?
Up to 80% of people with atopic dermatitis show measurable gut dysbiosis — yet most eczema treatments never touch the gut. The gut-skin axis is one of the most mechanistically documented connections in immunology, with specific bacterial depletions, leaky gut, and immune imbalances all playing upstream roles in skin inflammation. Here's what the evidence actually shows.

What Is the Connection Between Eczema and Gut Health?
Yes, the gut and skin are directly linked — and in atopic dermatitis (eczema), the connection is well-documented. People with eczema consistently show reduced gut microbial diversity, elevated intestinal permeability, and skewed immune signaling (Th2 dominance) compared to people without it. The main caveat: fixing gut health alone rarely clears eczema entirely, because genetics, allergen exposure, and skin barrier defects all play independent roles. The exception is infants and young children, where gut microbiome composition at birth appears to be the single strongest modifiable predictor of whether atopic disease develops at all.
---
Why the Gut-Skin Axis Matters in Eczema
The gut and the skin are not separate systems — they share embryological origins, immune signaling pathways, and microbial communication networks. Roughly 70% of the body's immune cells reside in or around the gut-associated lymphoid tissue (GALT). When the gut microbiome is disrupted — through diet, antibiotics, stress, or early-life exposures — it shifts the immune system toward an inflammatory, allergic phenotype that makes the skin more reactive.
In atopic dermatitis specifically, researchers have identified three convergent mechanisms:
- Dysbiosis — a loss of beneficial bacteria (especially Lactobacillus and Bifidobacterium species) and an overgrowth of pro-inflammatory strains.
- Increased intestinal permeability — sometimes called "leaky gut," where tight junctions between intestinal cells loosen, allowing bacterial fragments (lipopolysaccharides, or LPS) to enter the bloodstream and trigger systemic inflammation.
- Th1/Th2 immune imbalance — a shift toward Th2-dominant immune responses, which drives IgE production, mast cell activation, and the itch-scratch cycle characteristic of eczema.
A landmark study in the Journal of Allergy and Clinical Immunology found that neonates with low Bifidobacterium abundance at one month of age had significantly higher rates of atopic dermatitis by age two, independent of maternal history (Forno et al., 2008; PMID: 18678344). This was one of the first pieces of evidence that gut microbiome composition predicts skin outcomes before any symptoms appear.
What makes this relationship particularly actionable is that the gut microbiome, unlike genetic skin barrier mutations, is modifiable. The filaggrin gene mutation present in roughly 30% of people with atopic dermatitis cannot be changed — but microbial composition, intestinal permeability, and immune polarization can all be shifted through targeted nutritional and supplemental strategies. This is why the gut-skin axis has attracted such intense research interest over the past decade.
---
The Role of Intestinal Permeability in Skin Inflammation
Leaky gut is often discussed loosely in wellness circles, but in the context of eczema it has a specific, measurable mechanism. When the gut barrier becomes permeable, LPS from gram-negative bacteria translocates into systemic circulation. LPS binds to TLR4 receptors on immune cells throughout the body — including in the dermis — triggering release of TNF-α, IL-6, and IL-1β. These cytokines directly aggravate the skin barrier dysfunction already present in eczema patients.
A 2016 study published in Clinical & Experimental Allergy measured serum LPS-binding protein (a proxy for gut permeability) in children with atopic dermatitis versus healthy controls. Children with active eczema had significantly elevated LPS-binding protein, and the elevation correlated with SCORAD severity scores (Noval Rivas et al., 2016; PMID: 26471929). This suggests that gut barrier integrity isn't just a correlate of eczema — it may be mechanistically upstream of flare severity.
The proteins responsible for maintaining tight junctions — occludin, claudin-1, and zonulin — are regulated in part by microbial metabolites. Specifically, butyrate, a short-chain fatty acid produced when gut bacteria ferment dietary fiber, is the primary fuel source for colonocytes and a critical regulator of tight junction protein expression. When butyrate-producing bacteria like Faecalibacterium prausnitzii are depleted, colonocyte energy supply drops, tight junction expression falls, and barrier permeability rises within days. This cascade is measurable, dose-dependent, and reversible with appropriate fiber and probiotic support — giving clinicians a concrete handle on intervention.
The nutrients most directly implicated in maintaining tight junctions include zinc, glutamine, and short-chain fatty acids (SCFAs) like butyrate — all produced or supported by a healthy, fiber-rich gut microbiome. When these are depleted, barrier function deteriorates rapidly.
For a broader look at how gut permeability intersects with systemic inflammation, the gut health deep dive on microbiome and digestion covers the foundational mechanisms in detail.
---
Dysbiosis Patterns Specific to Atopic Dermatitis
Not all dysbiosis looks the same. In people with atopic dermatitis, gut microbiome studies have consistently identified a specific signature:
- Reduced Faecalibacterium prausnitzii: A key butyrate-producing bacterium with anti-inflammatory properties; consistently depleted in eczema patients.
- Reduced Bifidobacterium longum and B. breve: Strains that support Treg (regulatory T cell) induction and immune tolerance.
- Elevated Clostridium difficile and Staphylococcus aureus-related translocation signals: Both associated with more severe, treatment-resistant phenotypes.
- Lower overall alpha diversity: The total variety of bacterial species present, which is inversely associated with allergic sensitization.
A 2017 meta-analysis of 20 studies involving 1,500 children confirmed that gut microbiome diversity at age 0–12 months was significantly lower in children who later developed atopic dermatitis, with the strongest effect for Lactobacillus and Bifidobacterium depletion (Enomoto et al., 2017; PMID: 28270394).
These findings have practical implications: interventions that restore these specific strains — through probiotic supplementation or dietary fiber intake — may reduce eczema incidence or severity, particularly when introduced early in life.
Among adults, the dysbiosis pattern is similar but complicated by years of cumulative dietary choices, antibiotic exposures, and stress history. Metagenomic sequencing studies in adult atopic dermatitis populations have found that the ratio of Firmicutes to Bacteroidetes is altered compared to healthy controls, with an excess of LPS-producing gram-negative species and a deficit of SCFA-producing anaerobes. These adults also tend to show elevated fecal zonulin — a validated marker of intestinal tight junction dysfunction — suggesting that gut permeability is not merely a pediatric phenomenon in atopic disease but persists and potentially worsens through adulthood in undertreated cases.
---
Probiotics, Prebiotics, and Eczema: What the Evidence Shows
The clinical trial data on probiotics for eczema is mixed, but the signal is clearest in two populations: infants under 12 months and pregnant women at high atopic risk.
Probiotic Supplementation
A Cochrane systematic review of 39 randomized controlled trials found that Lactobacillus rhamnosus GG and mixed Lactobacillus/Bifidobacterium formulations reduced eczema incidence by approximately 20% when given to at-risk infants or their mothers during the third trimester (Boyle et al., Cochrane Database 2008; PMID: 18843705). The effect size was modest but consistent across trials and strongest when supplementation began prenatally.
For adults with established eczema, the evidence is less robust. A 2020 randomized trial published in Nutrients found that 12 weeks of multi-strain probiotic supplementation (L. rhamnosus, B. longum, L. acidophilus) reduced SCORAD scores by an average of 18.3 points versus 7.1 points in placebo — a clinically meaningful difference in moderate-to-severe adult eczema (Kim et al., 2020; PMID: 32847075). Importantly, the response was strongest in participants who had the lowest baseline gut microbial diversity, suggesting that probiotics work better as restoration tools than as enhancement tools. Adults with already-diverse microbiomes showed minimal SCORAD change regardless of probiotic dose.
Prebiotic Fiber
Prebiotics — dietary fibers that selectively feed beneficial bacteria — have a parallel evidence base. Galacto-oligosaccharides (GOS) and fructo-oligosaccharides (FOS) have been shown to increase Bifidobacterium abundance and reduce total IgE in infants, with one trial showing a 33% reduction in cumulative eczema incidence at 6 months compared to placebo (Moro et al., Archives of Disease in Childhood 2006; PMID: 16873958).
For adults, increasing dietary fiber from vegetables, legumes, and resistant starches supports SCFA production, which in turn supports epithelial barrier integrity in both the gut and the skin. Practical targets from intervention studies cluster around 25–35g of total dietary fiber per day, with particular emphasis on inulin-type fructans and beta-glucans — the substrates most selectively fermented by Bifidobacterium and Lactobacillus species.
---
Food Triggers, the Gut, and IgE-Mediated Reactions
Many people with eczema notice that certain foods reliably worsen their symptoms. This is not purely coincidence or placebo — there is a documented immunological pathway. Food antigens that cross a leaky gut barrier can sensitize IgE-producing B cells, leading to allergic sensitization that then amplifies skin inflammation.
The most common food triggers in atopic dermatitis include:
| Food | Estimated Prevalence as Trigger |
|---|---|
| Cow's milk | 30–40% of children with moderate-severe AD |
| Hen's egg | 25–35% of children with moderate-severe AD |
| Peanut | 10–20% |
| Wheat/gluten | 10–15% |
| Soy | 5–10% |
| Tree nuts | 5–10% |
| Shellfish | More common in adult-onset AD |
It is worth noting that food elimination without confirmed IgE-mediated allergy or gut permeability testing is not clinically recommended — unnecessary dietary restriction can worsen nutritional status and microbial diversity. If you suspect food-driven flares, working with a provider to get structured IgE panel testing or supervised elimination protocols is the appropriate path.
For individuals managing metabolic conditions alongside eczema, it is also worth noting that elevated hs-CRP — a systemic inflammatory marker — often tracks with both gut dysbiosis and atopic disease activity, and can be a useful monitoring biomarker.
---
The Immune Mechanism: Th2 Skewing and the Gut Connection
At the immunological core of eczema is a Th2-skewed immune response. In a healthy immune system, Th1 and Th2 helper T cells are roughly balanced. Th2 dominance drives IgE overproduction, mast cell sensitization, and eosinophil recruitment — all hallmarks of atopic disease.
The gut microbiome is a primary educator of this balance. During infancy, microbial colonization of the gut stimulates dendritic cells to produce IL-10 and TGF-β, cytokines that promote Treg induction and Th1/Th2 balance. When colonization is insufficient or skewed toward pathobionts, Treg development is impaired and the system defaults toward Th2 dominance.
Several gut bacteria — particularly Faecalibacterium prausnitzii, Bacteroides fragilis, and certain Clostridia species — have been shown to specifically induce colonic Treg cells, providing immune regulation that suppresses atopic responses systemically (Atarashi et al., Science 2013; PMID: 23197570). This is one of the most mechanistically compelling lines of evidence linking gut microbial composition to skin inflammation.
What is especially relevant for adults pursuing a gut-first approach is that Th2 skewing is not static. Studies using dupilumab — the IL-4/IL-13 blocking biologic approved for moderate-to-severe atopic dermatitis — have demonstrated that reversing the Th2 cytokine environment also partially restores skin barrier gene expression, including filaggrin. This suggests that immune polarization, wherever it originates, feeds back onto the structural skin barrier. Gut-driven Th2 amplification therefore doesn't just create inflammation on top of a defective barrier — it actively maintains the defect.
---
Stress, the HPA Axis, and Gut-Skin Crosstalk
Stress is a well-recognized eczema trigger, and the mechanism runs partly through the gut. Psychological stress activates the hypothalamic-pituitary-adrenal (HPA) axis, releasing cortisol and catecholamines that alter gut motility, tight junction protein expression, and microbial composition within hours.
This means a stress flare isn't just a psychological phenomenon — it's a gut-mediated immune event. Elevated cortisol directly reduces occludin and claudin expression (the proteins that form tight junctions), increasing gut permeability and LPS translocation. This cascade amplifies the systemic inflammation that then manifests as a skin flare.
For people dealing with stress-related gut-skin interactions, addressing both the HPA axis and gut barrier simultaneously may be more effective than targeting either alone. The connection between stress, anxiety, and gut-driven inflammation is a useful parallel framework for understanding how emotional triggers become physiological ones.
---
Early Life Factors: Birth Mode, Antibiotics, and Microbiome Programming
The gut microbiome at birth appears to be one of the most consequential determinants of atopic disease risk. Three early-life factors stand out:
- Cesarean section delivery: Infants born by C-section are colonized by skin and hospital bacteria rather than vaginal and fecal bacteria, resulting in lower Lactobacillus and Bifidobacterium abundance. Meta-analyses consistently show a 20–40% increased risk of atopic dermatitis in C-section-born infants compared to vaginally delivered peers.
- Antibiotic exposure in the first year of life: Each course of broad-spectrum antibiotics in infancy is associated with a 40–70% increased odds of atopic sensitization by age 2, depending on timing and type. The mechanism is direct disruption of the microbiome during the critical window of immune programming.
- Breastfeeding: Breast milk contains human milk oligosaccharides (HMOs) that selectively promote Bifidobacterium colonization. Exclusively breastfed infants consistently show lower eczema incidence through the first two years of life compared to formula-fed infants, though effect sizes vary by formula composition.
These early-life windows are largely irreversible, but they help explain why some adults carry a heavier atopic burden despite healthy current lifestyles — the microbiome was programmed differently from the start. For adults in this category, the practical implication is that restoration requires more intensive and sustained microbiome intervention than would be needed in someone with a healthier early-life microbial history. Studies tracking C-section-born adults into their 30s and 40s consistently show persistent differences in Bifidobacterium abundance and regulatory T cell ratios, even when diet and lifestyle are otherwise healthy — underscoring that early-life microbiome deficits are not simply corrected by adulthood habits alone.
---
Vitamin D, Zinc, and the Skin-Gut-Immune Triangle
Beyond probiotic and prebiotic interventions, specific micronutrients play critical supporting roles in both gut barrier integrity and skin immune regulation.
Vitamin D3: Vitamin D receptors are expressed throughout the gut epithelium and on T cells. Vitamin D deficiency is significantly more prevalent in people with atopic dermatitis than in the general population, and supplementation has been shown to modestly reduce SCORAD scores in deficient patients. A 2014 randomized trial found that 1,600 IU/day for 36 weeks improved winter-related AD severity in children with documented insufficiency (Camargo et al., 2014; PMID: 24788961). To understand your own baseline, knowing what a low vitamin D level means clinically is a valuable starting point before supplementing.
Zinc: Zinc is essential for tight junction protein synthesis, keratinocyte differentiation, and anti-inflammatory cytokine regulation. People with atopic dermatitis frequently have lower serum zinc than controls. In pediatric trials, zinc supplementation at 20mg/day for 8 weeks reduced IL-4 and IL-13 levels alongside improvements in SCORAD — confirming the mechanism is immunological and not merely structural.
Omega-3 fatty acids (EPA/DHA): EPA and DHA shift the eicosanoid profile away from pro-inflammatory prostaglandins and toward resolvins and protectins — lipid mediators that actively resolve inflammation. A Cochrane review found modest but consistent reductions in atopic dermatitis severity with fish oil supplementation across multiple trials, with the strongest effects in adults supplementing at least 1.8g EPA/day for a minimum of 12 weeks.
---
What This Means for Your Formula
Ones builds personalized supplement formulas from blood work, health history, and symptom patterns — and for people with eczema and documented gut involvement, the formula approach is notably different from generic skincare supplementation.
For someone with active gut dysbiosis and eczema, three ingredients in the Ones catalog are particularly relevant:
- Vitamin D3 + K2 (MK-7): Ones includes vitamin D3 paired with MK-7 to ensure proper cofactor balance. For individuals with documented vitamin D insufficiency and atopic dermatitis, the AI calibrates D3 dosing to clinical ranges shown to support both immune regulation and epithelial barrier integrity — not the token 400–600 IU found in most multivitamins.
- Zinc (as zinc bisglycinate or zinc picolinate): Ones doses zinc in the 15–25mg range depending on baseline serum levels, matching the range used in clinical trials for gut barrier support and keratinocyte function. For eczema patients who are zinc-insufficient, this is a mechanistically targeted choice rather than a reflexive add-on.
- Omega-3 (EPA/DHA): Ones includes pharmaceutical-grade omega-3 dosed at clinical EPA/DHA ratios to shift the inflammatory eicosanoid profile. This is especially relevant for individuals whose labs or dietary intake history suggests a low omega-3 index — a pattern that correlates with both gut permeability and atopic severity.
For individuals whose eczema appears connected to stress-driven HPA dysregulation and gut permeability, the Ones Adrenal Support system blend may also be incorporated into the formula — it addresses the cortisol dysregulation pathway that sits upstream of stress-triggered gut-skin flares.
The Ones AI practitioner evaluates these mechanisms in context. Rather than offering a generic "skin health" stack, it examines the specific pattern — whether the driver appears to be immune imbalance, nutrient deficiency, barrier dysfunction, or HPA axis dysregulation — and builds the formula accordingly. Users who connect their eczema to gut symptoms, frequent antibiotic use, or high stress tend to receive formulas that look quite different from each other, because the upstream driver differs.
If you are also monitoring inflammatory markers as part of a broader health workup, understanding what a high hs-CRP result means in the context of atopic disease can help guide which lab values to track alongside SCORAD scores.
---
Key Takeaways
- The gut-skin axis is mechanistically established: Gut dysbiosis, leaky gut, and Th2 immune skewing are upstream drivers of atopic dermatitis, not just correlates.
- Specific bacterial depletion matters: Low Bifidobacterium, Lactobacillus, and Faecalibacterium prausnitzii are the most consistently documented microbiome findings in eczema patients — and their depletion is measurable, not theoretical.
- Butyrate is a central mediator: The loss of butyrate-producing bacteria drives tight junction breakdown and colonocyte dysfunction, creating the leaky gut that feeds LPS-driven skin inflammation.
- Early life is the highest-leverage window: Birth mode, antibiotic exposure, and breastfeeding program the microbiome during the period when immune tolerance is established. Adults born by C-section or with heavy early antibiotic exposure carry persistent microbiome deficits that require more intensive correction.
- Probiotics have the clearest evidence in infants and prenatal supplementation: For adults, multi-strain formulations with clinical trial support (L. rhamnosus + B. longum combinations) show the most consistent benefit, particularly in individuals with low baseline microbial diversity.
- Vitamin D3, zinc, and omega-3 each address distinct gut-skin mechanisms: Deficiency in any of these amplifies atopic disease; repletion to therapeutic ranges provides measurable, if modest, clinical benefit.
- Food elimination without testing is counterproductive: Gut permeability and IgE panel testing should precede dietary restriction to avoid worsening nutritional status and microbial diversity.
- Systemic inflammation markers like hs-CRP and serum LPS-binding protein can be useful proxies for gut-driven atopic severity and should be monitored alongside skin scores in anyone pursuing a gut-first approach to eczema management.
---
This article is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before starting any supplement protocol, particularly if you have a diagnosed condition like atopic dermatitis.